Analyst
Top Stories
Sector Update | Automobile
June sales for five major Chinese automakers were mixed, with export growth offsetting domestic weakness. BYD and Geely outperformed on overseas and EVs, while Great Wall and Li Auto missed estimates; XPeng beat on the GX but H1 volumes lagged. Outlooks vary: BYD/Geely positive, Li Auto/Great Wall uncertain. We maintain MARKET WEIGHT; top BUYs include CATL, BYD, Geely, Minth, Ganfeng Lithium (BYD’s target price is raised to HK$135, while that for Geely and GWM are trimmed to HK$27.00 and HK$12.00 respectively). Top SELL is Li Auto.
Technical Analysis
Hansoh Pharmaceutical Group | 3692 HK
Support levels: HK$29.16/HK$28.14
Resistance levels: HK$34.56/HK$38.40
Sinotruk Hong Kong | 3808 HK
Support levels: HK$37.42/HK$35.54
Resistance levels: HK$45.24/HK$48.40
Top Stories
Sector Update | Automobile
June sales for five major Chinese automakers were mixed, with export growth offsetting domestic weakness. BYD and Geely outperformed on overseas and EVs, while Great Wall and Li Auto missed estimates; XPeng beat on the GX but H1 volumes lagged. Outlooks vary: BYD/Geely positive, Li Auto/Great Wall uncertain. We maintain MARKET WEIGHT; top BUYs include CATL, BYD, Geely, Minth, Ganfeng Lithium (BYD’s target price is raised to HK$135, while that for Geely and GWM are trimmed to HK$27.00 and HK$12.00 respectively). Top SELL is Li Auto.
Technical Analysis
Hansoh Pharmaceutical Group | 3692 HK
Support levels: HK$29.16/HK$28.14
Resistance levels: HK$34.56/HK$38.40
Sinotruk Hong Kong | 3808 HK
Support levels: HK$37.42/HK$35.54
Resistance levels: HK$45.24/HK$48.40
Analyst
IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at the following link: https://research-api.uobkayhian.com/assets/disclaimer/0e6d602f-adeb-45f8-9dea-5d5591daae87, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.
